Primary angioplasty should be first line treatment for acute myocardial infarction

BMJ

Volumn 328, Issue 7450, 2004, Pages 1254-1256

  Smith, David ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; METHODOLOGY; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; ACUTE HEART INFARCTION; ANGIOPLASTY; CARDIOVASCULAR RISK; CAUSE OF DEATH; DIAGNOSTIC APPROACH ROUTE; EXERCISE TEST; GOVERNMENT; HAZARD ASSESSMENT; HIGH RISK PATIENT; MORTALITY; POPULATION RISK; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SAFETY; TREATMENT INDICATION; UNITED KINGDOM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RISK FACTORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 2442659389     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.328.7450.1254     Document Type: Article

References (11)

1. Fath-Ordoubadi F, Huehns T, Al-Mohammad A, Beatt KJ Significance of the thrombolysis in myocardial infarction scoring system in assessing infarct-related artery reperfusion and mortality rates after acute myocardial infarction. Am Heart J 1997; 134: 62-68.
2. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-30.
3. French JK, Hyde TA, Patel H, Amos DJ, McLaughlin SC, Webber BJ, et al Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks. J Am Coll Cardiol 1999; 34: 62-69.
4. GUSTO Angiographic Investigators The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
5. Grines CL, Browne KF, Marco J Primary Angioplasty in Myocardial Infarction Study Group (PAMI) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-9.
6. Keeley EC, Boura JA, Grines CL Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
7. Garcia E, Elizaga J, Perez-Castellano N, Serrano JA, Soriano J, Abeytua M, et al Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999; 33: 605-11.
8. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
9. Grines CL, Marsalese DL, Brodie B, Griffin J, Donohue B, Costantini CR, et al Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1998; 31: 967-72.
10. Department of Health. National service framework for coronary heart disease. London: DoH, 2000. www.nelh.nhs.uk/nsf/chd/nsf/main/mainreport.htm (accessed 26 Apr 2004).
11. Smith LDR, Dean JW Primary angioplasty in the district general hospital. Interim analysis of the Exeter primary angioplasty pilot study. Heart 1997; 77 (suppl 1): 46.